OXB.L
Oxford BioMedica PLC
Price:  
423.50 
GBP
Volume:  
258,355.00
United Kingdom | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OXB.L WACC - Weighted Average Cost of Capital

The WACC of Oxford BioMedica PLC (OXB.L) is 10.4%.

The Cost of Equity of Oxford BioMedica PLC (OXB.L) is 9.30%.
The Cost of Debt of Oxford BioMedica PLC (OXB.L) is 15.70%.

Range Selected
Cost of equity 7.50% - 11.10% 9.30%
Tax rate 3.50% - 4.60% 4.05%
Cost of debt 7.00% - 24.40% 15.70%
WACC 7.4% - 13.5% 10.4%
WACC

OXB.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 0.59 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.50% 11.10%
Tax rate 3.50% 4.60%
Debt/Equity ratio 0.25 0.25
Cost of debt 7.00% 24.40%
After-tax WACC 7.4% 13.5%
Selected WACC 10.4%